Predictions
Tandem Diabetes Care Inc
Start price
Target price
Perf. (%)
€55.88
16.10.22
16.10.22
-
16.10.23
16.10.23
-27.47%
05.02.23
05.02.23
Novocure Ltd
Start price
Target price
Perf. (%)
€68.89
02.01.23
02.01.23
€30.00
31.12.25
31.12.25
71.43%
05.01.23
05.01.23
Could be very worthwhile Investment >20% year
Tandem Diabetes Care Inc
Start price
Target price
Perf. (%)
€136.00
28.12.21
28.12.21
€142.00
28.12.22
28.12.22
-70.42%
29.12.22
29.12.22
Could be worthwhile Investment >10% per year
Capable Management
Future proof or reliable business model
Opko Health Inc.
Start price
Target price
Perf. (%)
€4.65
28.12.21
28.12.21
-
28.12.22
28.12.22
-75.54%
29.12.22
29.12.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
Future proof or reliable business model
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€37.99
27.12.21
27.12.21
€42.00
27.12.22
27.12.22
-5.05%
28.12.22
28.12.22
Could be worthwhile Investment >10% per year
Neogen Corp.
Start price
Target price
Perf. (%)
€35.40
14.12.21
14.12.21
€38.00
14.12.22
14.12.22
-59.89%
15.12.22
15.12.22
Could be worthwhile Investment >10% per year
Mirati Therapeutics Inc.
Start price
Target price
Perf. (%)
€56.50
07.12.22
07.12.22
-
07.12.23
07.12.23
-30.27%
10.12.22
10.12.22
Could be worthwhile Investment >10% per year
Mirati Therapeutics Inc.
Start price
Target price
Perf. (%)
€47.20
07.12.22
07.12.22
-
07.12.23
07.12.23
-16.53%
10.12.22
10.12.22
Risky Investment
Ligand Pharmaceuticals
Start price
Target price
Perf. (%)
€63.78
04.11.22
04.11.22
-
04.11.23
04.11.23
23.24%
12.11.22
12.11.22
Tandem Diabetes Care Inc
Start price
Target price
Perf. (%)
€111.45
23.10.21
23.10.21
-
23.10.22
23.10.22
-50.65%
24.10.22
24.10.22
Tandem Diabetes Care Inc
Start price
Target price
Perf. (%)
€54.50
21.06.22
21.06.22
-
21.06.23
21.06.23
-7.34%
20.09.22
20.09.22
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€32.00
03.09.22
03.09.22
€16.00
03.09.23
03.09.23
-3.75%
17.09.22
17.09.22
Mirati Therapeutics Inc.
Start price
Target price
Perf. (%)
€76.50
21.08.22
21.08.22
€230.00
21.08.23
21.08.23
6.54%
04.09.22
04.09.22
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Probably not worthwhile Investment
Lower EBIT Margin than peer group
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€214.90
21.08.22
21.08.22
€87.00
21.08.23
21.08.23
-3.44%
04.09.22
04.09.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Tandem Diabetes Care Inc
Start price
Target price
Perf. (%)
€91.50
10.08.21
10.08.21
-
10.08.22
10.08.22
-42.25%
10.08.22
10.08.22
Global Blood Therapeutics Inc
Start price
Target price
Perf. (%)
€33.09
30.10.21
30.10.21
€45.00
31.12.23
31.12.23
94.65%
05.08.22
05.08.22
Could be very worthwhile Investment >20% year